<DOC>
	<DOCNO>NCT00136864</DOCNO>
	<brief_summary>Locally advanced non-small cell lung cancer , NSCLC , ( Stage III ) potentially curable aggressive combine modality therapy ( chemotherapy radiation ) . Conventional imaging evaluate gross anatomic abnormality functional image positron emission tomography ( PET ) may accurately identify patient benefit aggressive combine modality therapy . This prospective randomized clinical trial enroll 400 patient undergone conventional staging lung cancer find Stage III NSCLC . The patient randomize either standard combine modality therapy Stage III NSCLC PET image prior combine modality therapy curative intent . Based PET finding , patient either suitable combined modality therapy curative intent .</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) Imaging Stage III Non-small Cell Lung Cancer ( PET START Trial )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histological cytological evidence NSCLC . Must document pathology report histology indicate ( e.g . squamous , adenocarcinoma , large cell , NSCLC otherwise specify ) . Stage III ( mediastinal node positive ) NSCLC base conventional staging ( e.g . compute tomography [ CT ] scan chest upper abdomen , CT magnetic resonance image [ MRI ] brain , bone scan ) . Suitable combined modality ( chemotherapy radiation ) therapy radical radiation therapy trimodality therapy ( chemotherapy , radiation surgery ) . Stage IV NSCLC ( conventional staging ) . Small cell lung cancer . Poor performance status Eastern Cooperative Oncology Group ( ECOG ) 34 . Poor pulmonary function preclude radical radiation therapy ( Adequate pulmonary reserve radical radiation therapy . Pulmonary function test force expiratory volume 1 second ( FEV1 ) &gt; 1.0 liter &gt; 40 % predict , diffuse capacity lung carbon monoxide ( DLCO ) &gt; 45 % and/or predict contralateral FEV1 &gt; 800 cc base quantitative ventilation perfusion lung scan ) . Significant concurrent medical problem ( e.g . uncontrolled diabetes , active cardiac problem , significant chronic obstructive pulmonary disease ) . Insulin dependent diabetic requirement PET imaging may problematic . Unable lie supine least 30 minute radiation treatment position image PET . Failure provide informed consent . Previous PET scan relate recent cancer diagnosis prior entry study . Pregnant lactate female . Prior thoracic radiation . Prior malignancy within 3 year randomization ( except nonmelanotic skin cancer carcinoma situ cervix ) . Administered two cycle chemotherapy prior radical radiation therapy concurrent chemoradiation ( part induction sequential chemotherapy prior randomization ) current malignancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Positron-Emission Tomography</keyword>
	<keyword>PET Scan</keyword>
	<keyword>Non-Small-Cell Lung Carcinoma</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Radiation Oncology</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Oncology</keyword>
	<keyword>Radiation Planning</keyword>
</DOC>